Cancer Treatment

How Clay Siegall Has No Plans On His Company Being Acquired

Clay Siegall’s leadership has made Seattle Genetics, Inc. the most dominant biotechnology firm in the Pacific Northwest. Some investors have been wondering if this means his company will be acquired by an even larger firm in the healthcare industry or if it will continue to grow on its own and attracting top talent. Seattle Genetics […]

Eric Lefkofsky Eradicating Bottlenecks in Curing Cancer

Keeping in mind the end goal to treat disease effectively, specialists require information—yet they require information around a few things. What’s more, that is what’s absent from the present therapeutic research framework, as indicated by Eric Lefkofsky, prime supporter and CEO of Tempus, a startup expecting to set up databases to calibrate disease treatment. There’s […]